AETHLON MEDICAL INC — Form 8-K
Filed October 1, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
Aethlon Medical amended its 2020 Equity Incentive Plan effective August 11, 2026 (board approval) and October 1, 2026 (stockholder approval). The aggregate share reserve increased to 319,425 shares, comprising original 2,087 shares plus amendments adding 2,250 shares (Sept 2022), 37,500 shares (Sept 2024), 100,000 shares (Dec 2025), 92,000 new shares, plus returning shares from the prior 2010 plan and forfeitures. The plan permits grants of options, SARs, RSUs, restricted stock, and performance awards to employees, directors, and consultants.
Why this rating
Plan amendment is routine administrative disclosure. Share reserve of 319,425 represents ~5.6% of company's $5.7M market cap (assuming ~10-15M shares outstanding); material for equity dilution but typical for small-cap. No new funding, transaction, or business change.
See more from October 1, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.